Dr. Ashwini Bhat, MD

Dr. Bhat practices at Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas.

Dr. Bhat's NPI, 1396901856, was assigned on August 4, 2008. Dr. Bhat graduated from Government Medical College Vijayanagar in 2004. Dr. Bhat holds Texas license P1166.

Dr. Bhat's primary practice is Baylor Scott & White Continuing Care Hospital - Temple, at 2401 South 31st St, Temple, TX 76504 in Bell County. The practice phone is (254) 771-8200.

Dr. Bhat's primary practice is Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas. Dr. Bhat is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is Baylor Scott & White Temple Roney Bone and Joint Institute, Temple. Dmand AI also links Dr. Bhat to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhat practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bhat's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bhat is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Bhat's licenses on file in 2 states: Texas and New Jersey.

Dmand AI lists acute diabetes, bile duct problems, chronic anemia, chronic kidney disease, coronary artery disease, neuropathy, purpura and thrombocytopenia and tobacco use among the conditions Dr. Bhat treats.

CMS data shows 957 Medicare services from Dr. Bhat across 7 procedure codes in 2024, for 278 Medicare patients. Medicare paid $53,956 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 278 Medicare patients who saw Dr. Bhat in 2024. The largest group is 65 to 74, with 132 patients. 75% of them have cancer, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhat's median patient age at 73, with 82% women.

In 2024, Dr. Bhat wrote 1,147 Medicare Part D claims for 242 patients. 81% of them were for generic drugs. CMS names the drug for 984 of them, across 20 drugs with 11 or more claims each, at $2,631,874 in total drug cost. In 2023, CMS named 931 claims across 23 drugs.

Dr. Bhat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhat as offering telehealth.

Dmand AI links 1 paper to Dr. Bhat in 2022. Dr. Bhat's most frequent co-authors are Lubna Alhalabi, MD, Iftikhar J. Kullo, MD and Magdi Atef Zordok, MD.

Dmand AI links Dr. Bhat to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases. Open Payments lists research payments to Dr. Bhat that name 1 trial.

CMS Open Payments shows 19 general payments to Dr. Bhat from 9 drug and device companies from 2016 to 2024. Education make up the largest share, 57% of the total. Abbott Laboratories paid the most, $294. It also lists 2 research payments totaling $2,586 from 2023 to 2024, naming 1 clinical trial.

Dr. Bhat graduated from Government Medical College Vijayanagar in 2004.

Dr. Bhat is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.